EFFICACY AND SAFETY OF OFLOXACIN PLUS PIPERACILLIN IN THE TREATMENT OF ASPIRATION PNEUMONIA

Aspiration pneumonia is common and often serious lung disease. Prognosis could be improved by effective prevention, early diagnosis and appropriate drug regimens. Since anti-microbial therapy is the key stone of treatment, it has been an area of debate and controversy. We evaluate the efficacy and safety of intravenous ofloxacin plus piperacillin. Our bacteriologic results show frequent pluri micro-organism cultures in sputum and frequent isolation of staphylococci in culture specimens. Clinical and bacteriological results demonstrate that intravenous ofloxacin plus piperacillin is effective (success = 28/30) and safe (no side effects) for the treatment of aspiration pneumonia.